Cabot Corporation (NYSE:CBT) Given Average Recommendation of “Hold” by Analysts

Cabot Corporation (NYSE:CBT) has earned a consensus recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $73.75.

CBT has been the subject of a number of recent research reports. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Mizuho set a $75.00 price target on Cabot and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. Finally, JPMorgan Chase & Co. decreased their price objective on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th.

Institutional Investors Weigh In On Cabot

Institutional investors and hedge funds have recently bought and sold shares of the business. NewEdge Advisors LLC boosted its stake in shares of Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after acquiring an additional 947 shares during the period. Goldman Sachs Group Inc. raised its stake in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares during the period. Empowered Funds LLC raised its stake in Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after purchasing an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock worth $10,145,000 after purchasing an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. 93.18% of the stock is owned by institutional investors.

Cabot Stock Performance

CBT opened at $67.73 on Monday. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 11.86, a PEG ratio of 8.94 and a beta of 0.86. The company’s 50 day moving average is $72.88 and its 200 day moving average is $70.48. Cabot has a 12-month low of $58.33 and a 12-month high of $84.54.

Cabot (NYSE:CBT) last announced its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The business had revenue of $849.00 million during the quarter, compared to analysts’ expectations of $889.11 million. During the same period in the prior year, the company earned $1.76 earnings per share. The firm’s revenue was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, equities research analysts predict that Cabot will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Friday, February 27th were paid a dividend of $0.45 per share. The ex-dividend date was Friday, February 27th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.7%. Cabot’s payout ratio is 31.52%.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.